Core Viewpoint - Jianxin Superconducting (688805) has been listed on the Shanghai Stock Exchange, focusing on the research, production, and sales of core components for medical magnetic resonance imaging (MRI) equipment [1][2]. Company Overview - Jianxin Superconducting primarily engages in the development, production, and sales of key components for MRI equipment, including superconducting magnets, permanent magnets, and gradient coils, which account for approximately 50% of the cost of MRI equipment [2]. - The controlling shareholders are Xu Jianyi, Xu Hui, and Xu Dianbo, with a combined voting power of 59.92% prior to the issuance. After the issuance, their combined voting power will decrease to 44.94% [2]. Financial Information - The total amount raised from the issuance is 778.8736 million yuan, with a net amount of 688.6427 million yuan after deducting issuance costs. The funds will be used for projects including the annual production of 600 sets of liquid helium-free superconducting magnets, annual production of 600 sets of high-field medical superconducting magnets, and the research and development of new superconducting magnets [2].
今日上市:健信超导